UBS Group »

Aytu Biopharma shares owned by UBS Group

Quarter-by-quarter ownership of Aytu Biopharma (AYTU) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Aytu Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aytu Biopharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aytu Biopharma by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $738 260 2.84
2023-09-30 $11k 4.2k 2.70
2023-06-30 $416 260 1.60
2023-03-31 $12k 5.3k 2.24

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Aytu Biopharma

Nantahala Capital Management
Alyeska Investment Group
Vanguard Group
Goldman Sachs Group
Jpmorgan Chase & Co
Royal Bank of Canada
Advisor Group Holdings
UBS Group
Wells Fargo & Company
West Financial Advisors
CarsonAllaria Wealth Management
Citigroup
TSFG

View all funds holding Aytu Biopharma